179 related articles for article (PubMed ID: 15911048)
1. Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.
Memisoglu-Bilensoy E; Vural I; Bochot A; Renoir JM; Duchene D; Hincal AA
J Control Release; 2005 Jun; 104(3):489-96. PubMed ID: 15911048
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic evaluation of injectable cyclodextrin nanoparticles.
Memisoglu-Bilensoy E; Doğan AL; Hincal AA
J Pharm Pharmacol; 2006 May; 58(5):585-9. PubMed ID: 16640826
[TBL] [Abstract][Full Text] [Related]
3. Sterile, injectable cyclodextrin nanoparticles: effects of gamma irradiation and autoclaving.
Memisoglu-Bilensoy E; Hincal AA
Int J Pharm; 2006 Mar; 311(1-2):203-8. PubMed ID: 16413708
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
6. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Cırpanlı Y; Allard E; Passirani C; Bilensoy E; Lemaire L; Calış S; Benoit JP
Int J Pharm; 2011 Jan; 403(1-2):201-6. PubMed ID: 20951783
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Cavalli R; Donalisio M; Civra A; Ferruti P; Ranucci E; Trotta F; Lembo D
J Control Release; 2009 Jul; 137(2):116-22. PubMed ID: 19361545
[TBL] [Abstract][Full Text] [Related]
8. Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel.
Bilensoy E; Gürkaynak O; Ertan M; Sen M; Hincal AA
J Pharm Sci; 2008 Apr; 97(4):1519-29. PubMed ID: 17705171
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment.
Nguyen A; Marsaud V; Bouclier C; Top S; Vessieres A; Pigeon P; Gref R; Legrand P; Jaouen G; Renoir JM
Int J Pharm; 2008 Jan; 347(1-2):128-35. PubMed ID: 17643877
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo.
Ravikumara NR; Bharadwaj M; Madhusudhan B
J Biomater Appl; 2016 Nov; 31(5):755-772. PubMed ID: 27664187
[TBL] [Abstract][Full Text] [Related]
11. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
[TBL] [Abstract][Full Text] [Related]
12. Electrospray technique for solid lipid-based particle production.
Trotta M; Cavalli R; Trotta C; Bussano R; Costa L
Drug Dev Ind Pharm; 2010 Apr; 36(4):431-8. PubMed ID: 19788405
[TBL] [Abstract][Full Text] [Related]
13. Entrapment of epirubicin in poly(butyl cyanoacrylate) colloidal nanospheres by nanoprecipitation: formulation development and in vitro studies on cancer cell lines.
Yordanov G; Skrobanska R; Evangelatov A
Colloids Surf B Biointerfaces; 2012 Apr; 92():98-105. PubMed ID: 22154011
[TBL] [Abstract][Full Text] [Related]
14. Optimization of entrapment of metronidazole in amphiphilic beta-cyclodextrin nanospheres.
Lahiani-Skiba M; Bounoure F; Shawky-Tous S; Arnaud P; Skiba M
J Pharm Biomed Anal; 2006 Jun; 41(3):1017-21. PubMed ID: 16497467
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.
Teixeira M; Alonso MJ; Pinto MM; Barbosa CM
Eur J Pharm Biopharm; 2005 Apr; 59(3):491-500. PubMed ID: 15760730
[TBL] [Abstract][Full Text] [Related]
16. Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake.
Barbieri S; Sonvico F; Como C; Colombo G; Zani F; Buttini F; Bettini R; Rossi A; Colombo P
J Control Release; 2013 May; 167(3):276-83. PubMed ID: 23428841
[TBL] [Abstract][Full Text] [Related]
17. Direct formation of nanospheres from amphiphilic beta-cyclodextrin inclusion complexes.
Memişoğlu E; Bochot A; Ozalp M; Sen M; Duchêne D; Hincal AA
Pharm Res; 2003 Jan; 20(1):117-25. PubMed ID: 12608545
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the hydrophobic drug loading characteristics in nanoprecipitated amphiphilic cyclodextrin nanospheres.
Lemos-Senna E; Wouessidjewe D; Lesieur S; Puisieux F; Couarraze G; Duchêne D
Pharm Dev Technol; 1998 Feb; 3(1):85-94. PubMed ID: 9532603
[TBL] [Abstract][Full Text] [Related]
19. Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic beta-cyclodextrins.
Memişoğlu E; Bochot A; Sen M; Duchêne D; Hincal AA
Int J Pharm; 2003 Jan; 251(1-2):143-53. PubMed ID: 12527184
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen-loaded polymeric micelles: preparation, physico-chemical characterization and in vitro evaluation studies.
Cavallaro G; Maniscalco L; Licciardi M; Giammona G
Macromol Biosci; 2004 Nov; 4(11):1028-38. PubMed ID: 15529397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
